Literature DB >> 20190536

Cystic fibrosis-related diabetes in childhood.

Stephen M P O'Riordan1, Mehul T Dattani, Peter C Hindmarsh.   

Abstract

Since the early 1990s the management of children with cystic fibrosis (CF) has come a long way and advances in both nutritional and medical care have resulted in a median age of survival of 30-35 years, as compared with a life expectancy of <1 year in the 1950s. The first definitive reports of glucose intolerance or diabetes in CF are from 1955. The combination of CF and related diabetes (CFRD) has a negative impact on survival. CFRD is now the most common complication of CF (50% of the CF patients will develop diabetes by the age of 30 years), and is associated with a 6-fold increase in morbidity and mortality. CFRD is usually asymptomatic and can remain undetected for up to 4 years prior to diagnosis. The objective of this report was to review the current literature (Medline and Pubmed searches) on CFRD in children and adolescents and provide a comprehensive report of incidence, prevalence and pathophysiology of insulin deficiency and insulin insensitivity. Along with survival and prognosis in CFRD the current management strategies in the diagnosis, monitoring and treatment of CFRD will also be addressed.

Entities:  

Mesh:

Year:  2010        PMID: 20190536     DOI: 10.1159/000271912

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  15 in total

1.  Influence of Cystic Fibrosis-Related Diabetes on Mental Health in Adults: A Single-Center Study.

Authors:  Michelle Hjelm; Dmitry Tumin; Christopher J Nemastil; Ann E Salvator; Don Hayes
Journal:  Lung       Date:  2020-10-16       Impact factor: 2.584

2.  Reduced insulin sensitivity is correlated with impaired sleep in adolescents with cystic fibrosis.

Authors:  Stacey L Simon; Tim Vigers; Kristen Campbell; Laura Pyle; Rachael Branscomb; Kristen J Nadeau; Christine L Chan
Journal:  Pediatr Diabetes       Date:  2018-08-01       Impact factor: 4.866

3.  Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.

Authors:  Alicia K Olivier; Yaling Yi; Xingshen Sun; Hongshu Sui; Bo Liang; Shanming Hu; Weiliang Xie; John T Fisher; Nicholas W Keiser; Diana Lei; Weihong Zhou; Ziying Yan; Guiying Li; Turan I A Evans; David K Meyerholz; Kai Wang; Zoe A Stewart; Andrew W Norris; John F Engelhardt
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

4.  A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.

Authors:  Yaling Yi; Xingshen Sun; Katherine Gibson-Corley; Weiliang Xie; Bo Liang; Nan He; Scott R Tyler; Aliye Uc; Louis H Philipson; Kai Wang; Manami Hara; Katie Larson Ode; Andrew W Norris; John F Engelhardt
Journal:  Endocrinology       Date:  2016-02-10       Impact factor: 4.736

Review 5.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

Review 6.  Recombinant growth hormone therapy for cystic fibrosis in children and young adults.

Authors:  Vidhu Thaker; Alexandra L Haagensen; Ben Carter; Zbys Fedorowicz; Brian W Houston
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

7.  CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors.

Authors:  Xingshen Sun; Yaling Yi; Weiliang Xie; Bo Liang; Michael C Winter; Nan He; Xiaoming Liu; Meihui Luo; Yu Yang; Katie Larson Ode; Aliye Uc; Andrew W Norris; John F Engelhardt
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

8.  Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.

Authors:  Katja Konrad; Angelika Thon; Maria Fritsch; Elke Fröhlich-Reiterer; Eggert Lilienthal; Stefan A Wudy; Reinhard W Holl
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

9.  Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.

Authors:  Francesco Vetrini; Philip Ng
Journal:  Viruses       Date:  2010-09-03       Impact factor: 5.818

10.  Glucose derangements in very young children with cystic fibrosis and pancreatic insufficiency.

Authors:  Enza Mozzillo; Valeria Raia; Valentina Fattorusso; Mariateresa Falco; Angela Sepe; Fabiola De Gregorio; Rosa Nugnes; Giuliana Valerio; Adriana Franzese
Journal:  Diabetes Care       Date:  2012-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.